315 related articles for article (PubMed ID: 25581250)
21. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
Hoffmann-Vold AM; Molberg Ø; Midtvedt Ø; Garen T; Gran JT
J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316
[TBL] [Abstract][Full Text] [Related]
22. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
Schachna L; Medsger TA; Dauber JH; Wigley FM; Braunstein NA; White B; Steen VD; Conte JV; Yang SC; McCurry KR; Borja MC; Plaskon DE; Orens JB; Gelber AC
Arthritis Rheum; 2006 Dec; 54(12):3954-61. PubMed ID: 17133609
[TBL] [Abstract][Full Text] [Related]
23. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.
Humbert M; Yaici A; de Groote P; Montani D; Sitbon O; Launay D; Gressin V; Guillevin L; Clerson P; Simonneau G; Hachulla E
Arthritis Rheum; 2011 Nov; 63(11):3522-30. PubMed ID: 21769843
[TBL] [Abstract][Full Text] [Related]
24. Lung transplantation for scleroderma lung disease: An international, multicenter, observational cohort study.
Pradère P; Tudorache I; Magnusson J; Savale L; Brugiere O; Douvry B; Reynaud-Gaubert M; Claustre J; Borgne AL; Holm AM; Schultz HH; Knoop C; Godinas L; Fisher AJ; Hirschi S; Gottlieb J; Le Pavec J;
J Heart Lung Transplant; 2018 Jul; 37(7):903-911. PubMed ID: 29628135
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary survival study in 91 patients with systemic sclerosis.
Poormoghim H; Lakeh MM; Mohammadipour M; Talehy-Moineddin S; Sodagari F
Rheumatol Int; 2011 Dec; 31(12):1577-82. PubMed ID: 20496069
[TBL] [Abstract][Full Text] [Related]
26. Outcomes in systemic sclerosis-related lung disease after lung transplantation.
Sottile PD; Iturbe D; Katsumoto TR; Connolly MK; Collard HR; Leard LA; Hays S; Golden JA; Hoopes C; Kukreja J; Singer JP
Transplantation; 2013 Apr; 95(7):975-80. PubMed ID: 23545509
[TBL] [Abstract][Full Text] [Related]
27. Mortality in the Waikato Hospital Systemic Sclerosis Cohort.
Ooi C; Solanki K; Lao C; Frampton C; White D
Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628
[TBL] [Abstract][Full Text] [Related]
28. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
[TBL] [Abstract][Full Text] [Related]
29. An oversized allograft is associated with improved survival after lung transplantation for idiopathic pulmonary arterial hypertension.
Eberlein M; Diehl E; Bolukbas S; Merlo CA; Reed RM
J Heart Lung Transplant; 2013 Dec; 32(12):1172-8. PubMed ID: 23876630
[TBL] [Abstract][Full Text] [Related]
30. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of patients with systemic sclerosis-related interstitial lung disease on the lung transplant waiting list: a retrospective study.
Nakayama Y; Nakashima R; Handa T; Ohsumi A; Yamada Y; Nakajima D; Yutaka Y; Tanaka S; Hamada S; Ikezoe K; Tanizawa K; Shirakashi M; Hiwa R; Tsuji H; Kitagori K; Akizuki S; Yoshifuji H; Date H; Morinobu A
Sci Rep; 2023 Jun; 13(1):10150. PubMed ID: 37349495
[TBL] [Abstract][Full Text] [Related]
32. Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.
Hoffmann-Vold AM; Weigt SS; Palchevskiy V; Volkmann E; Saggar R; Li N; Midtvedt Ø; Lund MB; Garen T; Fishbein MC; Ardehali A; Ross DJ; Ueland T; Aukrust P; Lynch JP; Elashoff RM; Molberg Ø; Belperio JA
PLoS One; 2018; 13(11):e0206545. PubMed ID: 30457999
[TBL] [Abstract][Full Text] [Related]
33. Survival rate, causes of death, and risk factors in systemic sclerosis: a large cohort study.
Li X; Qian YQ; Liu N; Mu R; Zuo Y; Wang GC; Jia Y; Li ZG
Clin Rheumatol; 2018 Nov; 37(11):3051-3056. PubMed ID: 30225558
[TBL] [Abstract][Full Text] [Related]
34. Procedure Preference and Intention-to-Treat Outcomes after Listing for Lung Transplantation among U.S. Adults. A Cohort Study.
Anderson MR; Tabah A; RoyChoudhury A; Lederer DJ
Ann Am Thorac Soc; 2019 Feb; 16(2):231-239. PubMed ID: 30188172
[TBL] [Abstract][Full Text] [Related]
35. Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis.
Ryerson CJ; O'Connor D; Dunne JV; Schooley F; Hague CJ; Murphy D; Leipsic J; Wilcox PG
Chest; 2015 Nov; 148(5):1268-1275. PubMed ID: 25996795
[TBL] [Abstract][Full Text] [Related]
36. A decision model for the watch-and-wait strategy in systemic sclerosis-associated interstitial lung disease.
Kwon HM; Kang EH; Park JK; Go DJ; Lee EY; Song YW; Lee HJ; Lee EB
Rheumatology (Oxford); 2015 Oct; 54(10):1792-6. PubMed ID: 25972389
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Sobanski V; Giovannelli J; Lynch BM; Schreiber BE; Nihtyanova SI; Harvey J; Handler CE; Denton CP; Coghlan JG
Arthritis Rheumatol; 2016 Feb; 68(2):484-93. PubMed ID: 26415038
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
Fairley JL; Hansen D; Ross L; Proudman S; Sahhar J; Ngian GS; Walker J; Host LV; Morrisroe K; Apostolopoulous D; Ferdowsi N; Wilson M; Tabesh M; Stevens W; Nikpour M;
Arthritis Res Ther; 2023 May; 25(1):77. PubMed ID: 37173780
[TBL] [Abstract][Full Text] [Related]
39. Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease.
Mango RL; Matteson EL; Crowson CS; Ryu JH; Makol A
Lung; 2018 Aug; 196(4):409-416. PubMed ID: 29785507
[TBL] [Abstract][Full Text] [Related]
40. Prognostic profile of systemic sclerosis: analysis of the clinical EUSTAR cohort in China.
Hu S; Hou Y; Wang Q; Li M; Xu D; Zeng X
Arthritis Res Ther; 2018 Oct; 20(1):235. PubMed ID: 30348207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
